View in EDS

Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.

Saved in:
Bibliographic Details
Title: Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.
Authors: Monberg TJ; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Pakola SA; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland., Albieri B; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Ellebaek E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Eefsen RL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Borch TH; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Kudling TV; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland., Lorentzen T; Department of Gastroenterology, Copenhagen University Hospital, 2730 Herlev, Denmark., Hendel HW; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, 2730 Herlev, Denmark., Vestergaard C; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Lorentzen C; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Holmstroem RB; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Arias V; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland., Khammari A; Nantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, 44000 Nantes, France., Kistler C; TILT Biotherapeutics Ltd, Helsinki, Finland., Santos JM; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Clubb JHA; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Haybout L; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Westergaard MCW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark., Met Ö; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark; Department of Health Technology, Technical University of Denmark, 2800 Lyngby, Denmark., Quixabeira DCA; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Jirovec E; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland., Havunen R; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Sorsa S; TILT Biotherapeutics Ltd, Helsinki, Finland., Cervera-Carrascon V; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland., Dreno B; Nantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, 44000 Nantes, France., Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. Electronic address: akseli.hemminki@helsinki.fi., Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark. Electronic address: inge.marie.svane@regionh.dk.
Source: Cell reports. Medicine [Cell Rep Med] 2025 Mar 18; Vol. 6 (3), pp. 102016.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40107242
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Monberg+TJ%22">Monberg TJ</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Pakola+SA%22">Pakola SA</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Albieri+B%22">Albieri B</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Ellebaek+E%22">Ellebaek E</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Eefsen+RL%22">Eefsen RL</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Borch+TH%22">Borch TH</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Kudling+TV%22">Kudling TV</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Lorentzen+T%22">Lorentzen T</searchLink>; Department of Gastroenterology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Hendel+HW%22">Hendel HW</searchLink>; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Vestergaard+C%22">Vestergaard C</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Lorentzen+C%22">Lorentzen C</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Holmstroem+RB%22">Holmstroem RB</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Arias+V%22">Arias V</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Khammari+A%22">Khammari A</searchLink>; Nantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, 44000 Nantes, France.<br /><searchLink fieldCode="AU" term="%22Kistler+C%22">Kistler C</searchLink>; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Santos+JM%22">Santos JM</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Clubb+JHA%22">Clubb JHA</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Haybout+L%22">Haybout L</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Westergaard+MCW%22">Westergaard MCW</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Met+Ö%22">Met Ö</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark; Department of Health Technology, Technical University of Denmark, 2800 Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Quixabeira+DCA%22">Quixabeira DCA</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Jirovec+E%22">Jirovec E</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Havunen+R%22">Havunen R</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Sorsa+S%22">Sorsa S</searchLink>; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Cervera-Carrascon+V%22">Cervera-Carrascon V</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Dreno+B%22">Dreno B</searchLink>; Nantes Université, INSERM, CNRS, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302/EMR6001, 44000 Nantes, France.<br /><searchLink fieldCode="AU" term="%22Hemminki+A%22">Hemminki A</searchLink>; Cancer Gene Therapy Group, Translational Immunology Research Progam, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. Electronic address: akseli.hemminki@helsinki.fi.<br /><searchLink fieldCode="AU" term="%22Svane+IM%22">Svane IM</searchLink>; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark. Electronic address: inge.marie.svane@regionh.dk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101766894%22">Cell reports. Medicine</searchLink> [Cell Rep Med] 2025 Mar 18; Vol. 6 (3), pp. 102016.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101766894 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3791 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663791%22">26663791 </searchLink><i>NLM ISO Abbreviation: </i>Cell Rep Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40107242
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.xcrm.2025.102016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102016
    Titles:
      – TitleFull: Safety and efficacy of combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus TILT-123 in metastatic melanoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Monberg TJ
      – PersonEntity:
          Name:
            NameFull: Pakola SA
      – PersonEntity:
          Name:
            NameFull: Albieri B
      – PersonEntity:
          Name:
            NameFull: Ellebaek E
      – PersonEntity:
          Name:
            NameFull: Donia M
      – PersonEntity:
          Name:
            NameFull: Eefsen RL
      – PersonEntity:
          Name:
            NameFull: Borch TH
      – PersonEntity:
          Name:
            NameFull: Kudling TV
      – PersonEntity:
          Name:
            NameFull: Lorentzen T
      – PersonEntity:
          Name:
            NameFull: Hendel HW
      – PersonEntity:
          Name:
            NameFull: Vestergaard C
      – PersonEntity:
          Name:
            NameFull: Lorentzen C
      – PersonEntity:
          Name:
            NameFull: Holmstroem RB
      – PersonEntity:
          Name:
            NameFull: Arias V
      – PersonEntity:
          Name:
            NameFull: Khammari A
      – PersonEntity:
          Name:
            NameFull: Kistler C
      – PersonEntity:
          Name:
            NameFull: Santos JM
      – PersonEntity:
          Name:
            NameFull: Clubb JHA
      – PersonEntity:
          Name:
            NameFull: Haybout L
      – PersonEntity:
          Name:
            NameFull: Westergaard MCW
      – PersonEntity:
          Name:
            NameFull: Met Ö
      – PersonEntity:
          Name:
            NameFull: Quixabeira DCA
      – PersonEntity:
          Name:
            NameFull: Jirovec E
      – PersonEntity:
          Name:
            NameFull: Havunen R
      – PersonEntity:
          Name:
            NameFull: Sorsa S
      – PersonEntity:
          Name:
            NameFull: Cervera-Carrascon V
      – PersonEntity:
          Name:
            NameFull: Dreno B
      – PersonEntity:
          Name:
            NameFull: Hemminki A
      – PersonEntity:
          Name:
            NameFull: Svane IM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 03
              Text: 2025 Mar 18
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2666-3791
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Cell reports. Medicine
              Type: main
ResultId 1